WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
SNTI
SENTI BIOSCIENCES INC
$17.16M-85.00%-51.90%-69.62%-57.20%0.825.79100.00%-5,054.70%-5,054.67%
GYRE
GYRE THERAPEUTICS INC
$1.23B-2,139.50%-131.30%-72.78%-210.70%0.593.2296.00%-60.90%-53.06%
BNTC
BENITEC BIOPHARMA INC
$98.08M-175.40%-127.80%-187.41%787.20%0.304.18100.00%-309,885.70%-309,542.86%
GNLX
GENELUX CORP
$116.09M-127.60%-87.40%-152.65%-440.50%0.642.72100.00%-322,287.50%-321,912.50%
CYTK
CYTOKINETICS INC
$6.35BN/A-67.30%-69.82%-37.00%-3.047.19100.00%-14,141.70%-13,383.53%
ADTX
ADITXT INC
$3.48M-926.40%-188.20%-324.54%-233.40%1.830.09-27.20%-8,183.70%-6,839.92%
CELU
CELULARITY INC
$60.85M-144.20%-62.20%-246.75%-148.00%4.200.20-25.00%-1,226.70%-1,210.73%
LGVN
LONGEVERON INC
$7.84M-312.50%-171.30%-473.06%-394.60%2.190.7148.50%-2,210.80%-2,129.24%
NVCT
NUVECTIS PHARMA INC
$109.77M-141.60%-104.00%-159.62%406.80%0.413.46N/AN/AN/A
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INC
$5.29M-127.30%-115.60%-149.41%2,076.80%0.157.76N/AN/AN/A
REVB
REVELATION BIOSCIENCES INC
$3.25M-98.60%-62.70%-94.59%180.20%0.552.80N/AN/AN/A
XTLB
XTL BIOPHARMACEUTICALS LTD
$14.17M-57.30%-53.90%N/A-151.20%0.09N/AN/AN/AN/A
PHVS
PHARVARIS NV
$1.11B-39.70%-37.40%N/A-1,059.80%0.05N/AN/AN/AN/A
GOVX
GEOVAX LABS INC
$3.76M-346.20%-221.80%-51,181.90%1,985.30%60.870.87N/AN/AN/A
ANRO
ALTO NEUROSCIENCE INC
$333.36MN/AN/AN/AN/A0.0926.02N/AN/AN/A
SANA
SANA BIOTECHNOLOGY INC
$1.91B-89.20%-47.70%-49.10%-99.60%0.826.07N/AN/AN/A
VIRX
VIRACTA THERAPEUTICS INC
$31.69M-191.60%-79.50%-399.90%-107.40%2.731.35N/AN/AN/A
NMRA
NEUMORA THERAPEUTICS INC
$1.55BN/AN/AN/AN/A0.0617.99N/AN/AN/A
MURA
MURAL ONCOLOGY PLC
$63.80MN/AN/AN/AN/A0.1211.27N/AN/AN/A
ESLA
ESTRELLA IMMUNOPHARMA INC
$38.20M-153.60%-50.30%-71.72%141.60%0.0262.34N/AN/AN/A
ENSC
ENSYSCE BIOSCIENCES INC
$5.61M-511.50%-266.10%-289.15%57,643.40%0.442.87N/AN/AN/A
RARE
ULTRAGENYX PHARMACEUTICAL INC
$3.45B-425.60%-45.90%-57.96%-78.00%8.322.4388.60%-138.60%-139.00%
EDSA
EDESA BIOTECH INC
$15.24M-115.60%-88.90%-167.52%1,392.30%0.501.97N/AN/AN/A
TCBP
TC BIOPHARM (HOLDINGS) PLC
$5.44MN/AN/AN/AN/A5.720.88N/AN/AN/A
AVBP
ARRIVENT BIOPHARMA INC
$655.81MN/AN/AN/AN/A0.0332.82N/AN/AN/A
DARE
DARE BIOSCIENCE INC
$61.67MN/A-139.90%612.76%239.80%-2.180.5699.70%-1,024.90%-1,024.93%
DYN
DYNE THERAPEUTICS INC
$3.09B-110.90%-90.00%-51.49%-238.60%0.0921.83N/AN/AN/A
CRIS
CURIS INC
$62.01M-224.80%-60.90%-94.10%-136.10%5.564.0897.60%-486.40%-486.45%
CYBN
CYBIN INC
$144.34M-109.40%-98.20%-58.10%-7,001.60%0.075.76N/AN/AN/A
APLM
APOLLOMICS INC
$28.37MN/A-261.80%-412.23%-1,989.50%0.342.95N/AN/AN/A
PRTG
PORTAGE BIOTECH INC
$5.46M-232.80%-171.00%-367.80%-197.00%0.552.78N/AN/AN/A
CRGX
CARGO THERAPEUTICS INC
$803.66MN/AN/AN/AN/A0.1316.78N/AN/AN/A
CLRB
CELLECTAR BIOSCIENCES INC
$113.28M-1,855.60%-245.60%-191.60%503.40%0.642.54N/AN/AN/A
CKPT
CHECKPOINT THERAPEUTICS INC
$74.81MN/A-749.80%510.42%230.00%-2.170.54100.00%-76,938.20%-76,938.24%
VANI
VIVANI MEDICAL INC
$101.16M-93.90%-47.80%-53.25%-65.00%0.875.13N/AN/AN/A
CGON
CG ONCOLOGY INC
$1.98BN/AN/AN/AN/A0.0257.95N/AN/AN/A
CERE
CEREVEL THERAPEUTICS HOLDINGS INC
$7.66B-98.90%-45.10%-43.07%-39.00%1.0010.22N/AN/AN/A
IMNN
IMUNON INC
$12.88M-122.70%-84.10%-211.37%-180.60%0.692.51N/AN/AN/A
CHRO
CHROMOCELL THERAPEUTICS CORP
$10.50MN/A-848.30%-697.42%189.50%2.571.39N/AN/AN/A
SCPX
SCORPIUS HOLDINGS INC
$5.77M-101.40%-61.80%-109.95%-77.40%0.720.4760.90%-646.40%-643.50%
KYTX
KYVERNA THERAPEUTICS INC
$620.86MN/AN/AN/AN/A0.0817.17N/AN/AN/A
CARA
CARA THERAPEUTICS INC
$41.01M-174.20%-105.30%-159.94%-190.10%2.025.3875.20%-723.50%-708.22%
ASMB
ASSEMBLY BIOSCIENCES INC
$82.48M-120.60%-54.80%-63.26%-102.10%2.683.02N/AN/AN/A
CMMB
CHEMOMAB THERAPEUTICS LTD
$12.23M-109.90%-83.70%-142.22%-202.50%0.353.83N/AN/AN/A
KOD
KODIAK SCIENCES INC
$171.26M-81.10%-45.40%-56.78%-104.90%0.8010.12N/AN/AN/A
SLRX
SALARIUS PHARMACEUTICALS INC
$2.39M-152.20%-111.70%-244.34%700.00%0.343.91N/AN/AN/A
LXEO
LEXEO THERAPEUTICS INC
$453.66MN/A-58.70%-36.14%-722.40%0.179.16N/AN/AN/A
BCDA
BIOCARDIA INC
$10.70MN/A-261.70%742.60%2,590.70%-2.180.31100.00%-2,208.80%-2,208.76%
VCNX
VACCINEX INC
$8.71MN/A-461.20%-721.01%837.60%1.781.52100.00%-15,472.60%-15,472.58%
PHIO
PHIO PHARMACEUTICALS CORP
$3.60M-123.20%-98.60%-167.34%910.70%0.225.48N/AN/AN/A
VERU
VERU INC
$207.87M-96.20%-51.50%-54.52%-144.90%0.594.7234.10%-265.70%-251.71%
PROK
PROKIDNEY CORP
$898.99MN/A-8.10%-8.28%-11.20%-0.0217.62N/AN/AN/A
KALV
KALVISTA PHARMACEUTICALS INC
$501.20M-86.10%-72.70%-114.19%-116.90%0.295.44N/AN/AN/A
TPST
TEMPEST THERAPEUTICS INC
$72.65M-232.40%-79.00%-83.97%-115.70%1.153.13N/AN/AN/A
MTNB
MATINAS BIOPHARMA HOLDINGS INC
$42.14M-109.70%-85.70%-132.03%-109.10%0.355.15N/AN/AN/A
NAMS
NEWAMSTERDAM PHARMA CO NV
$1.79BN/AN/AN/AN/A0.198.17N/AN/AN/A
RNAZ
TRANSCODE THERAPEUTICS INC
$7.88M-534.80%-238.80%-370.62%1,994.40%0.592.48N/AN/AN/A
KZIA
KAZIA THERAPEUTICS LTD
$7.25M-186.40%-60.10%-122.43%1,002.70%3.630.71100.00%-68,256.80%-69,438.83%
ADXN
ADDEX THERAPEUTICS LTD
$8.81M-276.20%-156.00%-584.31%1,054.30%3.051.46100.00%-640.90%-620.33%
CNTX
CONTEXT THERAPEUTICS INC
$149.25M-136.00%-109.50%-252.55%987.00%0.314.23N/AN/AN/A
OMER
OMEROS CORP
$191.22MN/A-26.40%-23.82%-11.40%-7.134.76N/AN/AN/A
AVTX
AVALO THERAPEUTICS INC
$11.48MN/A-288.30%152.65%254.90%-2.000.5254.90%-9,853.70%-9,682.62%
ICCC
IMMUCELL CORP
$37.03M-15.20%-8.90%-10.02%-7.10%0.752.7127.60%-18.30%-18.29%
INBX
INHIBRX INC
$1.81B-678.50%-91.70%-110.17%-124.70%23.953.82100.00%-15,207.80%-13,390.07%
MBIO
MUSTANG BIO INC
$4.19M-1,243.20%-195.60%1,305.90%5,167.30%-3.950.53N/AN/AN/A
MRSN
MERSANA THERAPEUTICS INC
$338.94M-260.70%-54.00%-90.17%-168.80%6.093.51100.00%-352.00%-341.33%
PTCT
PTC THERAPEUTICS INC
$3.08BN/A-36.90%-41.41%-68.20%-3.002.0392.90%-62.40%-54.24%
SMMT
SUMMIT THERAPEUTICS INC
$3.19B-136.10%-55.50%-75.66%-52.20%3.006.97N/AN/AN/A
AKBA
AKEBIA THERAPEUTICS INC
$241.04MN/A-18.00%-22.68%-64.80%-9.271.7065.00%-23.00%-19.26%
IKT
INHIBIKASE THERAPEUTICS INC
$12.05M-147.00%-116.70%-287.13%-302.40%0.632.55100.00%-9,797.30%-10,013.87%
EYEN
EYENOVIA INC
$39.86M-349.60%-108.90%-307.16%-157.00%13.400.88200.00%-369,519.70%-339,946.75%
TRVN
TREVENA INC
$7.46MN/A-103.10%-150.94%-533.00%-3.133.6148.00%-1,279.00%-1,150.65%
CSBR
CHAMPIONS ONCOLOGY INC
$64.71M-850.70%-32.60%-200.46%-94.90%-14.020.6040.10%-19.80%-19.62%
EVAX
EVAXION BIOTECH A
$14.10M-1,238.10%-126.70%-365.79%-160.70%-3.731.18100.00%-30,308.20%-29,087.67%
MREO
MEREO BIOPHARMA GROUP PLC
$457.29MN/AN/AN/AN/A0.314.86N/AN/AN/A
APVO
APTEVO THERAPEUTICS INC
$3.04M-219.20%-109.70%-238.45%-417.20%1.891.92N/AN/AN/A
GLSI
GREENWICH LIFESCIENCES INC
$168.47M-118.00%-113.40%-180.44%2,881.10%0.0814.14N/AN/AN/A
MGX
METAGENOMI INC
$250.64MN/AN/AN/AN/A0.514.75N/AN/AN/A
BHVN
BIOHAVEN LTD
$3.47B-147.10%-113.60%-156.33%-249.70%0.394.03N/AN/AN/A
UNCY
UNICYCIVE THERAPEUTICS INC
$39.86MN/A-138.90%-166.69%252.90%-1.251.71N/AN/AN/A
PHGE
BIOMX INC
$18.89M-242.00%-74.40%-171.39%-152.30%7.121.58N/AN/AN/A
NERV
MINERVA NEUROSCIENCES INC
$17.34MN/A-53.20%-66.28%1,553.10%-2.3812.58N/AN/AN/A
TOVX
THERIVA BIOLOGICS INC
$6.39M-49.30%-33.00%-47.63%-102.40%0.473.60N/AN/AN/A
SAVA
CASSAVA SCIENCES INC
$1.06B-34.80%-28.30%-60.95%2,945.20%0.981.74N/AN/AN/A
BIVI
BIOVIE INC
$28.74M-301.60%-132.60%-169.65%-1,521.90%0.682.45N/AN/AN/A
ANEB
ANEBULO PHARMACEUTICALS INC
$55.76M-123.00%-109.30%-185.66%3,207.00%0.205.32N/AN/AN/A
CVM
CEL SCI CORP
$68.24M-218.00%-98.50%-117.02%-92.60%1.101.67N/AN/AN/A
FNCH
FINCH THERAPEUTICS GROUP INC
$3.60M-68.10%-28.10%-38.01%-31.80%1.636.05N/AN/AN/A
GANX
GAIN THERAPEUTICS INC
$45.31M-213.30%-129.00%-220.01%-578.90%0.692.77N/AN/AN/A
EPRX
EUPRAXIA PHARMACEUTICALS INC
$105.09MN/AN/AN/AN/A0.951.95N/AN/AN/A
GLPG
GALAPAGOS NV
$1.92BN/AN/AN/AN/A0.519.91N/AN/AN/A
VSTM
VERASTEM INC
$294.03M-158.00%-65.80%-104.34%-147.70%3.094.40N/AN/AN/A
BCAB
BIOATLA INC
$118.12M-140.40%-88.30%-170.49%695.10%0.794.49N/AN/AN/A
TLSA
TIZIANA LIFE SCIENCES LTD
$79.38M-140.90%-91.50%-305.44%-509.70%1.201.12N/AN/AN/A
GUTS
FRACTYL HEALTH INC
$333.84MN/AN/AN/AN/A0.949.38N/AN/AN/A
NEXI
NEXIMMUNE INC
$4.40M-328.20%-186.00%-593.54%-5,858.40%2.201.30N/AN/AN/A
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
$12.36M-403.40%-205.20%-314.82%-456.60%1.161.60N/AN/AN/A
CGEN
COMPUGEN LTD
$155.74MN/AN/AN/AN/A0.914.29N/AN/AN/A
ACXP
ACURX PHARMACEUTICALS INC
$35.33M-308.50%-193.30%-267.61%545.20%0.522.93N/AN/AN/A
XLO
XILIO THERAPEUTICS INC
$46.14M-155.60%-90.50%-139.07%-441.60%2.212.19N/AN/AN/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 64, which is 42 points higher than the biotech industry average of 22. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 17.21% over the past year, overperforming other biotech stocks by 38 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 40.81% from Corcept Therapeutics's current stock price of $28.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 42 points higher than the biotech industry average of 22. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -11.18% over the past year, overperforming other biotech stocks by 10 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 31.01% from Incyte's current stock price of $57.19.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third best biotech stock with a Zen Score of 62, which is 40 points higher than the biotech industry average of 22. It passed 21 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -16.61% over the past year, overperforming other biotech stocks by 4 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $39.80, an upside of 33.92% from Harmony Biosciences Holdings's current stock price of $29.72.

Harmony Biosciences Holdings stock has a consensus Hold recommendation according to Wall Street analysts. Of the 5 analysts covering Harmony Biosciences Holdings, 40% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 20% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 2 biotech stocks that have issued dividends in the past year, the 2 biotech stocks with the highest dividend yields are:

1. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.03%, which is the same as the biotech industry average of 0.72%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

2. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.39%, which is the same as the biotech industry average of 0.72%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 25.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.74% in the last day, and up 2.09% over the last week. Scorpius Holdings was the among the top gainers in the biotechnology industry, gaining 55.34% yesterday.

Scorpius shares are trading higher after the company announced expansion in San Antonio with a new storage and testing facility.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -17.68% in the past year. It has overperformed other stocks in the biotech industry by 3 percentage points.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -11.18% in the past year. It has overperformed other stocks in the biotech industry by 10 percentage points.

3. Avrobio (NASDAQ:AVRO)


Avrobio (NASDAQ:AVRO) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Avrobio has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Avrobio's stock has gained 6.11% in the past year. It has overperformed other stocks in the biotech industry by 27 percentage points.

Are biotech stocks a good buy now?

51.73% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 77.15% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 8.16x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.